Kieren Patel, Ph.D., M.B.A., Esq.

Kieren Patel, Ph.D., M.B.A., Esq. has a diverse work experience in various industries and roles. Kieren is currently serving as the Chief Business Officer at Resolve Biosciences since March 2023. Prior to this, they worked as the Chief Advisor at Willis & Smith Capital starting from January 2020. In May 2022, they joined Optum as an Enterprise Design, Product & Digital Strategy Advisor. From August 2020, they were the Head of Product and Marketing at Quantum-Si, a company focused on next-generation protein sequencing. Before that, they co-founded and served as the CEO of Opticent Health, a global ophthalmic diagnostics company starting from June 2014.

Kieren also has experience in the legal field. Kieren worked as a Principal | Intellectual Property at Venture Strategy Law Group from September 2013. Kieren served as a Patent Attorney, providing patent counseling and technology transfer services with a focus on life sciences. Additionally, they have experience at Wilson Sonsini Goodrich & Rosati, where they worked as a Scientific Advisor, providing strategic patent counseling in various industries.

In their previous roles, Kieren has held positions in marketing and product management. At Illumina, they worked as the Global Product Manager for NextSeq 1000/2000, where they played a significant role in launching NextSeq 2000 and developing the NextSeq 2000 GTM strategy. Kieren also served as the Global Product Manager for NovaSeq, overseeing a $1 billion sequencing product portfolio at Illumina. Prior to that, at BD, they worked as the Strategic Marketing and Global Product Manager for Genomics, leading the launch of the 'Rhapsody' product system and managing all aspects of product management.

Earlier in their career, Kieren had a fellowship at INVO and served as a Fellow. Kieren also worked at Wilson Sonsini Goodrich & Rosati as a Scientific Advisor, providing strategic patent counseling and conducting patent prosecutions.

Overall, Kieren Patel, Ph.D., M.B.A., Esq. has a strong background in business, law, and the life sciences industry, with experience in executive leadership, marketing, product management, and intellectual property.

Kieren Patel, Ph.D., M.B.A., Esq. holds an impressive educational background. Kieren first attended Harvard-Westlake School from 1994 to 2000. After completing high school, they pursued a Bachelor's degree in Cell/Cellular and Molecular Biology from Cornell University. Subsequently, Kieren furthered their education by attending the University of California, Berkeley, where they earned a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology. Additionally, they attended Northwestern University to obtain a Master of Business Administration (MBA), and Northwestern University Pritzker School of Law, where they earned a Doctor of Law (JD).